
What happened
Cresud Inc (NASDAQ: CRESY) CEO and director Alejandro Gustavo Elsztain bought 17,334 American Depositary Shares across 2026-09-30 to 2026-10-01. He paid $11.63 on 2026-09-30 and $11.3661 on 2026-10-01, for about $199,282 total. After the purchase, Elsztain held 1,243,098 shares beneficially owned.
Table I shows 8,573 ADS bought on 2026-09-30 and 8,761 ADS bought on 2026-10-01. Both lines are marked direct ownership. The filing lists Elsztain as a director, 10% owner and CEO. It reports no derivative securities. The later price was slightly below the first day's $11.63, so the buy was spread across two sessions.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| Shares bought | 17,334 shares | SEC Form 4 | |
| Purchase value | about $199,282 | SEC Form 4 | |
| Price per share | from $11.37 to $11.63 per share | SEC Form 4 | |
| Shares held after purchase | 1,243,098 shares | SEC Form 4 | |
| Purchase size vs prior holding | 1.4% | Calculated from SEC Form 4 |
Why it matters
OptimistFi's case is that Cresud is a hard-asset, Argentina-levered value story. Its upside depends on farmland, agriculture and real estate keeping real value while management turns cyclical cash flow into shareholder value. Elsztain's purchase fits that view because it adds to the CEO and director's direct stake at reported prices. OptimistFi's calculation puts the 17,334 shares at about 1.4% of the holding before the trade.
The two prices are close together. That points to buying across two sessions, not a single block.
That makes the buy a measured add, not a broad change in exposure. The main caveat is size, since the trade is small next to the existing 1,225,764-share base. For investors, the key point is that the purchase adds to an already large direct stake, not a small token position. Because the filing is an ownership report, investors can only read it as a signal about commitment.
Browse: stock research on every company OptimistFi covers
What's next
The filing leaves Elsztain with 1,243,098 shares. A later Form 4 from Elsztain would be the next dated evidence on whether he keeps adding. Another direct buy would reinforce the same signal. No additional buy would leave the reading unchanged.
If the next filing shows more buying, the insider signal gets stronger. If it shows no further purchase, the latest buy remains the current benchmark for his direct ownership.
More from OptimistFi
- CRESY stock: the Cresud thesis, its status and the next test to watch
- Fair Isaac Corporation (NYSE: FICO) Faces Equal Mortgage Pricing
- Broadcom Inc. (NASDAQ: AVGO) Has a $42 Billion Anthropic Test
- Autonomix Medical, Inc. (NASDAQ: AMIX) Gets a Clearer FDA Path
- Stock research on every company OptimistFi covers
- Latest stock research and investment-case updates
- OptimistFi: evidence-first equity research
Sources
- SEC Form 4 — Reports Alejandro Gustavo Elsztain's purchases of American Depositary Shares and his post-trade beneficial ownership.
Read the full OptimistFi thesis on Cresud Inc: https://optimistfi.com/stocks/CRESY
See what would break the Cresud Inc thesis and track it live on the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
The full Cresud Inc investment case, its status and the next test to watch live on the Cresud Inc thesis page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
